Pathophysiological relevance offorkhead transcription factors in brain ischemia

Advances in Experimental Medicine and Biology

Volumn 665, Issue , 2009, Pages 130-142

  Fukunaga, Kohji ^a   Shioda, Norifumi ^b  

^a TOHOKU UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIM PROTEIN; BIS(1 OXY 2 PYRIDINETHIOLATO)OXOVANADIUM; CALCINEURIN; FAS LIGAND; PROTEIN KINASE B; RESVERATROL; SIRTUIN 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR FOXO4; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG; VANADATE SODIUM; VANADIUM DERIVATIVE; VANADYL SULFATE; FORKHEAD TRANSCRIPTION FACTOR;

ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN NERVE CELL; CELL NUCLEUS; CYTOPLASM; ENZYME ACTIVITY; HIPPOCAMPUS; HUMAN; MOLECULAR INTERACTION; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; MOUSE; PHYSIOLOGY; REVIEW;

CAENORHABDITIS; GERBILLINAE; MAMMALIA;

ANIMALS; BRAIN ISCHEMIA; FORKHEAD TRANSCRIPTION FACTORS; MICE;

EID: 77952493900     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-1599-3_10     Document Type: Article

References (88)

1. Lin K, Dorman JB, Rodan A, et al. daf-16: An HNF-3/forkhead family member th at can function to double the life-span ofCaenorhabditis elegans. Science 1997; 278:1319-1322. (Pubitemid 27495748)
2. Furuyama T, Nakazawa T, Nakano I, et al. Identification of the differntial distribution patterns ofmRNAs and consensus binding sequences for mouse DAF-16 homologues. Biochem J 2000; 349:629-634. (Pubitemid 30465799)
3. Nakae J, Park BC , Acci li D. Insulin stimulates phosphorylation of the Forkhead transcription factor FKHR on serine 253 through a wortmannin-sensitive pathway. J Bioi Chern 1999; 274 :15982-15985.
4. Brunet A, Park J, Tran H, et al. Protein kinase SGK mediates survival signals by phosphorylating the Forkhead tran scription factor FKHRLI (FOX03a). Mol Cell Bioi 2001; 21:952-965. (Pubitemid 32104742)
5. Nakae J, Barr V, Accili D. Differential regulation of gene expression by insulin and IGF-l recepto rs correlates with phosphorylation of a single amino acid residue in the forkhead transcription factor FKHR. EMBO J 2000 ; 19:989-996. (Pubitemid 30119824)
6. Zhao X, Gan L, Pan H, et al. Multiple elements regulate nuclear/cytoplasmic shuttling of FOX01: Charactyerizarion of phosphorylanion- and 14-3-3-dependent and -independent mechanisms. Biochem J 2004; 378:839-849. (Pubitemid 38406861)
7. Rena G, Woods YL, Precott AR, et al. Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion. EMBO J 2002; 21:2263-2271. (Pubitemid 34516785)
8. Woods YL, Rena G, Morrice N, et al. The kinase DYRKIA phosphorylates the transcription factor FKHR at Ser329 in vitro, a novel in vivo phosphorylation site. BiochemJ 2001 ; 355:597-607. (Pubitemid 32434075)
9. Brunet A, Bonni A, Zigmond MJ, et al. Ala promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999; 96:857-868. (Pubitemid 29165088)
10. Takaishi H, Konishi H, Matsuzaki H, et al. Regulation ofnuclear translocation of Forkhead transcription factor AFX by protein kinase B. Proc Natl Acad Sci USA 1999; 96:11836-11841. (Pubitemid 29502819)
11. Biggs III WH, Meisenhelder J, Hunter T, et al. Protein kinase B/Ala-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc Natl Acad Sci USA. 1999; 96:7421-7426. (Pubitemid 29299677)
12. Rena G, Guo S, Cichy SC, et al. Phosphorylation of the transcription factor Forkhead family member FKHR by protein kinase B.J Bioi Chem 1999; 274:17179-17183.
13. Essers MAG, Weijzen S, de Vries-SmitsAMM, et al. FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBOJ 2004; 23:4902-4812.
14. Lehtinen MK, Yuan Z, Boag PR, et al. A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span. Cell 2006; 125:987-1001. (Pubitemid 43795191)
15. Davila D, Torres-Aleman I. Neuronal death by oxidarive stress involves activation of FOX03 through a two-arm pathway that activates stress kinases and attenuates insulin-like growth factor signaling. Mol Bioi Cell 2008; 19:2014-2025.
16. Huang H, Regan KM, Lou Z, et al. CDK2-dependent phosphorylation of FOXOI as an apoptptic response to DNA damage. Science 2002; 314:294-297.
17. Cheung PC, Salt IP, Davies SP, et al. Characterization of AKP-activated protein kinase gamma-subunit isoforms and their role in AMP binding. BiochemJ 2000; 346:659-669. (Pubitemid 30171026)
18. Hardie DG, Scott LW, Pan DA, et al. Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett 2003; 546: 113-120. (Pubitemid 36782291)
19. McCullough LD, Zehg Z, Li H, et al. Pharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke. J Bioi Chem 2005; 280 :20493-20502. (Pubitemid 40776749)
20. Greer EL, Oskoui PR, Banko MR, et al. The energysensor AMP-activated protein kinase 6recdy regulares the mammalian FOX03 transcription factor.J Bioi Chem 2007; 282:31107-30119.
21. Fukunaga K, Kawano T. Akris amolecular target for transduction therepy in brain ischemia. J Pharmacol Sci 2003 ; 92:317-327. (Pubitemid 37098256)
22. Datta SR, Brunet A, Greenberg ME. Cellular survival: A play in three Akts. Genes Dev 1999 ; 13:2905-2927.
23. Burgering BM, Kops GLPL. Cell cycle and death control: Long live Forkheads. Trends Biochem Scis 2002 ; 27:352-360 (Pubitemid 34756518)
24. Kawano T, Fukunaga K, Takeuchi Y, et al. Neuroprorective effect of sodium orthovanadate on delayed neuronal death afi:er transient forebrain ischemia in gerbil hippocampus J Cereb Blood Flow Metab 2001 ; 21:1268-1280. (Pubitemid 33130939)
25. Kawano T, Morioka M, Yano S, et al. Decreased Ala activity is associated with activation of Forkhead transcription factor afi:er transient forebrain ischemia in gerbil hippocampus. J Cereb Blood Flow Metab 2002; 22:926-934 (Pubitemid 34831599)
26. Hasegawa Y, Hamada J, Morioka M, et al. Neuroprotective effect of postischemic administration of sodium orthovanadate in rats with transient middle cerebral artery occlusion. J Cereb Blood Flow Metab 2003; 23:1040-1051. (Pubitemid 37082429)
27. Yano S. Morioka M, Fukunaga K, et al. Activation of Akr/Protein kinase B contributes to induction of ischemic tolerance in the CAl subfield of gerbil hippocampus.J Cereb Blood Flow Metab 2001 ; 21:351-360. (Pubitemid 32298882)
28. Alessi DR, Andjelkovic M, Caudwell BF, et al. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBOJ 1996; 15:6541-6551. (Pubitemid 26413787)
29. Tang ED, Nunez G, Barr FG, et al. Negative regulation of the Forkhead transcription factor FKHR by Akr.} Bioi Chem 1999; 274:16741-16746.
30. Datta SR, Dudek H, Tao X, et al. Akrphosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997; 91:231-241. (Pubitemid 27456390)
31. Del Peso L, Gonzalez -Garcia M, Page C, et al. Interleukin-3-induced phosphorylation of BAD through the protein kinase Ala. Science 1997; 278:687-689. (Pubitemid 27464966)
32. Blume-jensen P, janknechr R, Hunter T. The kit receptor promotes cell survival via activation of PI 3-kinase and subsequent Akr-mediated phosphorylation of Bad on Ser 136. CUrt Bioi 1998; 8:779-782. (Pubitemid 28301165)
33. Cardone MH, Roy N, Stennicke HR, et al. Regulation of cell death protease caspase-9 by phosphorylation. Science 1998; 282:1318-1321. (Pubitemid 28524494)
34. Kops GJ, de Ruiter ND, De Vries-Smits AM, et al. Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature 1999; 398:630-634 (Pubitemid 29183692)
35. Du K, Montminy M. CREB is a regulatory target for the protein kinase Akt/PKB. J Bioi Chern 1998; 273:32377-32379. (Pubitemid 28557606)
36. Romashkova JA, Makarov SS. NF-KB is a target of Akt in anti-apoprotic PDGF sigualling. Nature 1999; 401:86-90.
37. Shioda N, Ishibami T, Han F, et al. Activation of phosphatidylinositol3- kinse/orotein kinase B pathwsy by a vanadyl compound mediates its neuroprptective effect in mouse brain ischemia. Neuroscience 2007; 148:221-229. (Pubitemid 47211622)
38. Klee CB, Ren H, Wang X. Regulation of the Calmodulin-stimulated Protein Phosphatase, Calcineurin. J Bioi Chern 1998; 273:13367-13370. (Pubitemid 28268368)
39. Wang KK, Roufogalis BD, Villalobo A. Characterization of the fragmented forms of calcineurin produced by calpain 1.Biochem Cell Bioi 1989; 67:703-711. (Pubitemid 20055747)
40. Perrino BA, Ng LY, Soderling TR. Calcium regulation of calcineurin phosphatase activity by its B subunit and calmodulin. Role of the autoinhibitory domain J Bioi Chern 1995; 270:340-346.
41. Shibasaki F, McKeon F. Calcineurin functions in Ca'+-activated cell death in mammalian cells. J Cell Bioi 1995; 131:735-743.
42. Asai A, Qiu JH, Narita Y, et al. High Level Calcineurin Activity Predisposes Neuronal Cells to Apoptosis J Bioi Chern 1999; 274:34450-34458. (Pubitemid 129511792)
43. Wang HG, Pathan N, Ethell IM, et al. Cav-induced apoptosis through calcineurin dephosphorylation of BAD. Science 1999; 284:339-343. (Pubitemid 129523456)
44. Wu HY, Tomizawa K, Oda Y, et al. Critical role of calpain-mediated cleavageof calcineurin in excitotoxic neurodegeneration. J Bioi Chern 2004 ; 279:4929-4940. (Pubitemid 38199089)
45. Liu F, Grundke-Iqbal I, Iqbal K, et al. Truncation and activation ofcalcineurin A by calpain I in Alzheimer disease brain J Bioi Chern 2005; 280:37755-37762. (Pubitemid 41642385)
46. Shioda N, Moriguchi S, Shirasaki Y, et al. Gene ration of constitutively active calcineurin by calpain contributes to delayed neuronal death following mouse brain ischemia. J Neurochem 2006; 98:310-320. (Pubitemid 43882955)
47. Shioda N, Han F, Moriguchi S, et al. Constitutively active calcineurin mediates delayed neuronal death through Pas-ligand expression via activation of NFAT and FKHR tran scriptional activities in mouse brain ischemia. J Neurochem 2007; 102:1506-1517. (Pubitemid 47256193)
48. Park CH, Kim YS, Kim YH, et al. Calcineurin mediates AKT dephosphorylation in the ischemic rat retina Brain Res 2008 ; 1234:148-157.
49. Rao A, Luo C, Hogan PG. Transcription factors of the NFAT family: Regulation and function Annu Rev Immunol1997; 15:707-747. (Pubitemid 27169297)
50. Crabtree GR, Olson EN. NFAT signaling: Choreographing the social lives of cells. Cell 2002; 109:67-79.
51. Shibasaki F, Price ER, Milan D, et al. Role of kinases and the phosphatase calcineurin in the nuclear shuttling of transcription factor NF-AT4. Nature 1996; 25:370-373. (Pubitemid 26260467)
52. Nagata S. Apoptosis by death factor. Cell 1997; 88:355-365 (Pubitemid 27131377)
53. Luo X, Budihardjo I, Zou H, et al. Bid, a bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998; 94:481-490. (Pubitemid 28391864)
54. Li H, Zhu H, Xu CJ, et al. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis Cell 1998; 94:491-501. (Pubitemid 28391865)
55. Dijkers PF, Medema RH, Lammers JWJ, et al. Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHRL-1. Curr Bioi 2000; 10:1201-1204
56. Harrison DC, Roberts J, Campbell CA, et al. TR3 death receptor expression in the normal and ischemic brain Neuroscience 2000 ; 96:147-160 (Pubitemid 30103613)
57. Marrin-Villalba A, Herr I, Jeremias I, et al. CD95 ligand (Fas-LJAPO-IL) and tumor necrosis factor-related apopro sis-inducing ligand mediate ischemia-induced apoptosis in neurons J Neurosci 1999; 19:3809-3817. (Pubitemid 29222257)
58. Herdegen T, Claret FX, Kallunki T, et al. Lasting N-Terminal phosphorylation of c-jun and activation of c-jun N terminal kinases after neuronal injury. J Neurosci 1998; 18:5124-5135. (Pubitemid 28311930)
59. Rosenbaum DM, Gupta G, D'Amore Jet al. Fas (CD95/APO-l) play a role in the pathophysiology of focal cerebral ischemia. J Neurosci Res 2000 ; 61:686-692.
60. Gilley J, Coffer PL, Ham J. FOXO transcription factors directly activate bim gene expression and promote apoprosis in sympathetic neurons. J Cell Bioi 2003 ; 162:613-622 (Pubitemid 37022939)
61. Shinoda S, Schindler CK, Meller R, et al. Bim regulation may determine hippocampal vulnerability after sezures and in temporal lobe epilepsy. J Clinical Invest 2004 ; 113:1059-1068. (Pubitemid 38544128)
62. Fukunaga K, Ishigami T, Kawano T. Transcriptional regulation of neuronal genes and its effect on neural functions: Expression and function of forkhead transcription factors in neurons. J Pharmacol Sci 2005 ; 98:205-211. (Pubitemid 41296399)
63. Essaf A, Fernandez de Mattos S, Hassen YA, et al. Direct transcriptional regulation of Bim by Fox03a mediates STI571 -induced apoptos is in Bcr-Abl-expressing cells. Oncogene 2005; 24:2317-2329. (Pubitemid 40546691)
64. Bouillet P, MetcalfD, Huang DC, et al. Proapoptotic BcI-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis and to preclude autoimmunity. Science 1999; 286:1735-1738. (Pubitemid 129515880)
65. O'Reilly LA, Cullen L, Visvader J, et al. The proapoptotic BH3-only protein bim is expressed in hematopoietic, epithelial, neuronal and germ cells. Am J Parhol 2000; 157:449-461. (Pubitemid 30626908)
66. Shibata M, Hattori H, Sasaki T, et al. Temporal profiles of the subcellular localization of Bim, a BH3-only protein, during middle cerebral artery occlusion in mice. J Cereb Blood Flow Metab 2002; 22:810-820. (Pubitemid 34747598)
67. White BC, Sullivan JM, DeGracia DJ, et al. Brain ischemia and reperfusion : Molecular mechanisms of neuronal injury. J Neurol Sci 2000; 179:1-33.
68. Luo J, Nikolaev AY, Imai S, et al. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 2001; 107:137-148. (Pubitemid 33035941)
69. Brunett A, Sweeney LB, Sturgill JF, et al. Stress-dependent regulation of FOXO transcription factors by the SIRTl deacetylase. Science 2004; 303:2011-2015. (Pubitemid 38393275)
70. Nemoto S, Fergusson MM, Finkel T. Nutrient availability regulates SIRTI through a forkhead-dpendent pathway. Science 2004; 306:2105-2108 (Pubitemid 40007664)
71. Yeung F, Hoberg JE, Ramsey CS, et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRTI deacetylase. EMBO J 2004; 23:2369-2380. (Pubitemid 38954844)
72. Motta MC, Divecha N, Lemieux M, et al. Mammallian SIRTI repress forkhead transcript ion factor. Cell 2004; 116:551-563.
73. Fukuoka M, Dairoku H, Hatta M, et al. Negative regulation of forkhead transcription factor AFX (Fox04) by CBP-induced acetylation. Int J Mol Med 2003; 12:503-508.
74. van der Horst A, Teroolen LG, de Vries-Smits LM, et al. FOXO is acerylated upon peroxide stress and deacetylated by the longevity protein hSir2(SIRT1) J Bioi Chern 2004; 279:28873-28879. (Pubitemid 38915754)
75. Daitoku H, Harta M, Matsuzaki H, et al. Silent information regulator 2 potentiates Foxol-mediared transcr iption through its deacetylase activity. Proc Natl Acad Sci USA 2004; 102:10042-10047 (Pubitemid 38891191)
76. Giannakou ME, Partridge L. The interaction between FOXO and SIRTI: Tipping the balance towards survival. Trend Cell Bioi 2004; 14:408-412. (Pubitemid 39092697)
77. Hasegawa Y, Morioka M, Hasegawa S, et al. Therapeutic time window and dose dependence of neuroprotective effects of sodium orthovanadate following transient middle cerebral artery occlusion in rats. J Pharmacol Exp Therap 2006; 317:875-881.
78. Matsumoto J, Morioka M, Hasegawa Y, et al. Sodium orthovanadare enhances proliferation of progenitor cells in the adult rat subventricular zone after focal cerebral ischemia. J Pharmacol Exp Ther 2006; 318:982-991. (Pubitemid 44268303)
79. Shioda N, Han F, Morioka M, et al. Bis(l-oxy-2-pyridinethiolato) oxovanadium(IV) enhances neurogenesis via phosphatidylinos itol 3-kinase/Akt and extracellular signal regulated kinase activation in the hippocampal subgranular zone after mouse focal cerebral ischemia. Neuroscience 2008; 155:876-887.
80. Takada Y, Hashimoto M, Kasahara J, et al. Cytoprotective effect of sodium orthovanadate on ischemia/ reperfusion-induced injury in the rat heart involvesAkt activation and inhib ition of fodrin breakdown and apoptosi s. J Pharmacol Exp Therap 2004; 311:1249-1255. (Pubitemid 39612734)
81. Md Bhuiyan S, Shibuya M, Shioda M, et al. Cyroproteccive effect of bi(l-oxy-2-pyridinethiolato) oxovanadium(IV) on myocardial ischemia/reperfusion injury elicits inhibition of Fas ligand and Bim expression and elevation ofFUP expression. Eur J Pharmacol2007; 571:180-188. (Pubitemid 47379683)
82. Md Bhuiyan S, Takada Y, Shioda N, et al. Card ioprotective effect of vanadyl sulfate on ischemia/ reperfusion-induced injury in rat heart in vivo is medisted by activation ofprotein kinase B and induction of FUCE-inhibitory protein. Cardiovas Therap 2008; 26:10-23. (Pubitemid 351421781)
83. Md Bhuiyan S. Shioda N. ShibuyaM, et al. Activation of endothelial nitric oxide synthase by as vanadium compound ameliorates pressure overload-induced cardiac injury in ovariectomized rats. Hypertension 2009 ; 53:57-63.
84. Mocanu MM, Yellon DM. P53 down-regulation - a new molecular mechanism involved in ischaemic preconditioning. FEBS lett 2003; 555:302-306. (Pubitemid 37486045)
85. Tomasevic G, Shamloo M, Israeli D, et al. Activation of p53 and its target genes p21(WAFlICipl) and PAG608/Wig-l in ischemic preconditioning. Brain Res Mol Braib Res 1999; 70:304-313 (Pubitemid 29317646)
86. Raval AP, Dave KR, Perez-PinzonMA. Resveratolmimics ischemic preconditioning in the brain. J Cereb Blood Flow Merab 2006; 26:1141-1147.
87. Jang JH , Surh YJ. Protective defect of resveratol on beta-amyloid-induced oxdatvive PC12 cell death. Free Radic Bioi Med 2003; 34:1100-1110.
88. Maswood N, Young J, Tilmont E, et al. Caloric restriction increases neurotrophic facto levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease. Proc Natl Acad Sci USA 2004; 101:18171-18176. (Pubitemid 40054092)